Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uveal Melanoma × Diet Therapy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 11 Breast Neoplasms 11 Obesity 7 Colorectal Neoplasms 6 Motor Activity 5 Malnutrition 5 Polycystic Ovary Syndrome 4 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Radiation Injuries 3 Pancreatic Neoplasms 3 Overweight 3 Melanoma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Weight Loss 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Insulin Resistance 2 Head and Neck Neoplasms 2 Glioblastoma 2 Fatigue 2

Interventions

Ipilimumab 25 Nivolumab 19 pembrolizumab 11 incomplete Freund's adjuvant 10 Cyclophosphamide 9 Melphalan 8 Interleukin-2 8 sargramostim 7 MART-1 Antigen 7 CTLA-4 Antigen 7 Temozolomide 6 Ranibizumab 6 tebentafusp 5 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Dacarbazine 5 aldesleukin 4 aflibercept 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Blood Specimen Collection 4 Biopsy 4 Bevacizumab 4 trametinib 3 sotrastaurin 3 fludarabine phosphate 3 fludarabine 3 binimetinib 3 Vorinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04645680 2026-01-30

DIET

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡